Overview
Precipio Diagnostics provides hematology-focused cancer diagnostics services, combining expert pathology review with advanced molecular testing to reduce misdiagnosis rates for patients with blood cancers.
More in Clinical Diagnostics
Latest industry news
GenePlanet Secures Strategic Investment From Lauxera, Setting Its Sights on Unicorn Status
2026-11-01 · Funding
Motley Fool Names 7 Best Genomics Stocks for 2026, Signaling Renewed Investor Confidence in the Sector
2026-10-31 · Industry
Singapore's National Precision Medicine Program Shows How Genomic Data Can Actually Change Clinical Care
2026-10-30 · Research
Guardant Health's FDA-Cleared Genomic-Epigenomic Liquid Biopsy Panel Reshapes the Oncology Testing Landscape
2026-10-29 · Product
Company details
Category
🏥 Clinical Diagnostics
Location
New Haven, CT, USA
Funding
Publicly traded — NASDAQ: PRPO
Website
precipiodx.comListed
2026-08-03
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →